关于“局部晚期前列腺癌的心血管死亡率与雄激素剥夺治疗持续时间：RTOG 92-02分析”的社论评论 - Suppr

Suppr

超能文献

Editorial comment on: Cardiovascular mortality and duration of androgen deprivation for locally advanced prostate cancer: analysis of RTOG 92-02.

作者信息

Whelan Peter

出版信息

Eur Urol. 2008 Oct;54(4):823-4. doi: 10.1016/j.eururo.2008.01.022. Epub 2008 Jan 15.

DOI:10.1016/j.eururo.2008.01.022

PMID:18243509

Abstract

摘要

相似文献

Editorial comment on: Cardiovascular mortality and duration of androgen deprivation for locally advanced prostate cancer: analysis of RTOG 92-02.

Eur Urol. 2008 Oct;54(4):823-4. doi: 10.1016/j.eururo.2008.01.022. Epub 2008 Jan 15.

Cardiovascular mortality and duration of androgen deprivation for locally advanced prostate cancer: analysis of RTOG 92-02.

Eur Urol. 2008 Oct;54(4):816-23. doi: 10.1016/j.eururo.2008.01.021. Epub 2008 Jan 15.

Testosterone suppression in men with prostate cancer is associated with increased arterial stiffness.

Aging Male. 2002 Dec;5(4):216-22.

Cardiovascular mortality after androgen deprivation therapy for locally advanced prostate cancer: RTOG 85-31.

J Clin Oncol. 2009 Jan 1;27(1):92-9. doi: 10.1200/JCO.2007.12.3752. Epub 2008 Dec 1.

Acceptability of short term neo-adjuvant androgen deprivation in patients with locally advanced prostate cancer.

Radiother Oncol. 2003 Sep;68(3):255-67. doi: 10.1016/s0167-8140(03)00193-2.

What is the role of androgen deprivation therapy in the treatment of locally advanced prostate cancer?

Nat Clin Pract Urol. 2008 Nov;5(11):584-5. doi: 10.1038/ncpuro1217. Epub 2008 Sep 23.

Androgen deprivation therapy, insulin resistance, and cardiovascular mortality: an inconvenient truth.

J Androl. 2008 Sep-Oct;29(5):534-9. doi: 10.2164/jandrol.108.005454. Epub 2008 Jun 20.

Cardiovascular disease with androgen deprivation: the (forgotten) role of testosterone.

J Clin Oncol. 2009 Dec 10;27(35):e261; author reply e262. doi: 10.1200/JCO.2009.25.4078. Epub 2009 Nov 2.

Metabolic and cardiovascular effects of androgen deprivation therapy.

BJU Int. 2008 Dec;102(11):1509-14. doi: 10.1111/j.1464-410X.2008.07933.x. Epub 2008 Aug 22.

Unexpected enlargement of clinically silent pituitary gonadotroph adenoma induced by goserelin acetate given as treatment for prostate cancer.

Int J Urol. 2011 Jan;18(1):83-4. doi: 10.1111/j.1442-2042.2010.02676.x. Epub 2010 Nov 16.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Editorial comment on: Cardiovascular mortality and duration of androgen deprivation for locally advanced prostate cancer: analysis of RTOG 92-02.

作者信息

Whelan Peter

出版信息

Eur Urol. 2008 Oct;54(4):823-4. doi: 10.1016/j.eururo.2008.01.022. Epub 2008 Jan 15.

DOI:10.1016/j.eururo.2008.01.022

PMID:18243509

Abstract

摘要

相似文献

Editorial comment on: Cardiovascular mortality and duration of androgen deprivation for locally advanced prostate cancer: analysis of RTOG 92-02.

Eur Urol. 2008 Oct;54(4):823-4. doi: 10.1016/j.eururo.2008.01.022. Epub 2008 Jan 15.

Cardiovascular mortality and duration of androgen deprivation for locally advanced prostate cancer: analysis of RTOG 92-02.

Eur Urol. 2008 Oct;54(4):816-23. doi: 10.1016/j.eururo.2008.01.021. Epub 2008 Jan 15.

Testosterone suppression in men with prostate cancer is associated with increased arterial stiffness.

Aging Male. 2002 Dec;5(4):216-22.

Cardiovascular mortality after androgen deprivation therapy for locally advanced prostate cancer: RTOG 85-31.

J Clin Oncol. 2009 Jan 1;27(1):92-9. doi: 10.1200/JCO.2007.12.3752. Epub 2008 Dec 1.

Acceptability of short term neo-adjuvant androgen deprivation in patients with locally advanced prostate cancer.

Radiother Oncol. 2003 Sep;68(3):255-67. doi: 10.1016/s0167-8140(03)00193-2.

What is the role of androgen deprivation therapy in the treatment of locally advanced prostate cancer?

Nat Clin Pract Urol. 2008 Nov;5(11):584-5. doi: 10.1038/ncpuro1217. Epub 2008 Sep 23.

Androgen deprivation therapy, insulin resistance, and cardiovascular mortality: an inconvenient truth.

J Androl. 2008 Sep-Oct;29(5):534-9. doi: 10.2164/jandrol.108.005454. Epub 2008 Jun 20.

Cardiovascular disease with androgen deprivation: the (forgotten) role of testosterone.

J Clin Oncol. 2009 Dec 10;27(35):e261; author reply e262. doi: 10.1200/JCO.2009.25.4078. Epub 2009 Nov 2.

Metabolic and cardiovascular effects of androgen deprivation therapy.

BJU Int. 2008 Dec;102(11):1509-14. doi: 10.1111/j.1464-410X.2008.07933.x. Epub 2008 Aug 22.

Unexpected enlargement of clinically silent pituitary gonadotroph adenoma induced by goserelin acetate given as treatment for prostate cancer.

Int J Urol. 2011 Jan;18(1):83-4. doi: 10.1111/j.1442-2042.2010.02676.x. Epub 2010 Nov 16.